VANESSA HAWKINS: Open Payments
NPI 1083489983 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,031 in 52 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,110 · 2025 $3,031
Food & beverage: $1,956Long term medical supply or device loan: $981Education: $95
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $981 |
| E.R. Squibb & Sons, L.L.C. | 11 | $517 |
| Celgene Corporation | 18 | $478 |
| Daiichi Sankyo Inc. | 2 | $289 |
| Phathom Pharmaceuticals, Inc. | 1 | $145 |
| Janssen Biotech, Inc. | 1 | $126 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Eisai Inc. | 1 | $122 |
| Astellas Pharma US Inc | 2 | $121 |
| Merck Sharp & Dohme LLC | 2 | $61 |
Products named: KISQALI, OPDIVO, REBLOZYL, OPDUALAG, Enhertu, VOQUEZNA, RYBREVANT, OJJAARA.
Industry payments across CA — which companies pay providers there.
